Topic: National Cancer Research Network; Subtopic: Melanoma; Disease: Melanoma research hub

A study of pazopanib in metastatic merkel cell carcinoma

This clinical trial is testing a targeted drug called pazopanib in adults with a rare skin cancer called Merkel cell carcinoma. It is for people whose cancer has spread or cannot be removed with surgery, to see if the medicine can help shrink tumours and slow cancer growth.